Cyclin-dependent kinases in brain development and disease - PubMed (original) (raw)

Review

Cyclin-dependent kinases in brain development and disease

Susan C Su et al. Annu Rev Cell Dev Biol. 2011.

Abstract

Cyclin-dependent kinase 5 (Cdk5) is a multifaceted serine/threonine kinase protein with important roles in the nervous system. Two related proteins, p35 and p39, activate Cdk5 upon direct binding. Over the past decade, Cdk5 activity has been demonstrated to regulate many events during brain development, including neuronal migration as well as axon and dendrite development. Recent evidence also suggests a pivotal role for Cdk5 in synaptic plasticity, behavior, and cognition. Dysfunction of Cdk5 has been implicated in a number of neurological disorders and neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Niemann-Pick type C disease, and ischemia. Hyperactivation of Cdk5 due to the conversion of p35 to p25 by the calcium-dependent protease calpain during neurotoxicity also contributes to the pathological state. This review surveys recent literature surrounding Cdk5 in synaptic plasticity and homeostasis, with particular emphasis on Cdk5 kinase activity under neurodegenerative conditions.

PubMed Disclaimer

Similar articles

• [Roles of cyclin-dependent kinase 5 in central nervous system development and neurodegenerative diseases].
  Chen J, Wang ZF. Chen J, et al. Sheng Li Xue Bao. 2010 Aug 25;62(4):295-308. Sheng Li Xue Bao. 2010. PMID: 20717630 Review. Chinese.
• The role of CDK5/P25 formation/inhibition in neurodegeneration.
  Camins A, Verdaguer E, Folch J, Canudas AM, Pallàs M. Camins A, et al. Drug News Perspect. 2006 Oct;19(8):453-60. doi: 10.1358/dnp.2006.19.8.1043961. Drug News Perspect. 2006. PMID: 17160145 Review.
• Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory.
  Angelo M, Plattner F, Giese KP. Angelo M, et al. J Neurochem. 2006 Oct;99(2):353-70. doi: 10.1111/j.1471-4159.2006.04040.x. J Neurochem. 2006. PMID: 17029592 Review.
• Alternative roles for Cdk5 in learning and synaptic plasticity.
  Hawasli AH, Bibb JA. Hawasli AH, et al. Biotechnol J. 2007 Aug;2(8):941-8. doi: 10.1002/biot.200700093. Biotechnol J. 2007. PMID: 17597494 Review.
• Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
  Kesavapany S, Zheng YL, Amin N, Pant HC. Kesavapany S, et al. Biotechnol J. 2007 Aug;2(8):978-87. doi: 10.1002/biot.200700057. Biotechnol J. 2007. PMID: 17526058 Review.

Cited by

• Activation of Aurora-A is essential for neuronal migration via modulation of microtubule organization.
  Takitoh T, Kumamoto K, Wang CC, Sato M, Toba S, Wynshaw-Boris A, Hirotsune S. Takitoh T, et al. J Neurosci. 2012 Aug 8;32(32):11050-66. doi: 10.1523/JNEUROSCI.5664-11.2012. J Neurosci. 2012. PMID: 22875938 Free PMC article.
• PAK1 regulates cortical development via promoting neuronal migration and progenitor cell proliferation.
  Pan X, Chang X, Leung C, Zhou Z, Cao F, Xie W, Jia Z. Pan X, et al. Mol Brain. 2015 Jun 5;8:36. doi: 10.1186/s13041-015-0124-z. Mol Brain. 2015. PMID: 26043730 Free PMC article.
• Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review.
  Łukasik P, Załuski M, Gutowska I. Łukasik P, et al. Int J Mol Sci. 2021 Mar 13;22(6):2935. doi: 10.3390/ijms22062935. Int J Mol Sci. 2021. PMID: 33805800 Free PMC article. Review.
• Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity.
  Chen J, Li S, Sun W, Li J. Chen J, et al. PLoS One. 2015 Apr 14;10(4):e0123864. doi: 10.1371/journal.pone.0123864. eCollection 2015. PLoS One. 2015. PMID: 25875370 Free PMC article.
• Perinatal Hypoxic-Ischemic Encephalopathy and Neuroprotective Peptide Therapies: A Case for Cationic Arginine-Rich Peptides (CARPs).
  Edwards AB, Anderton RS, Knuckey NW, Meloni BP. Edwards AB, et al. Brain Sci. 2018 Aug 7;8(8):147. doi: 10.3390/brainsci8080147. Brain Sci. 2018. PMID: 30087289 Free PMC article. Review.

Publication types

MeSH terms

Substances

Grants and funding

• R01 NS051874/NS/NINDS NIH HHS/United States
• T32 MH074249/MH/NIMH NIH HHS/United States
• HHMI/Howard Hughes Medical Institute/United States
• R01 NS 051874/NS/NINDS NIH HHS/United States

LinkOut - more resources

• Full Text Sources

  • Ingenta plc

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal